Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Replacement: Director/PDMR Shareholding

20 May 2016 14:33

RNS Number : 9068Y
Cello Group plc
20 May 2016
 

The following amendments have been made to the 'Director's Dealing' announcement released on 20 May 2016 at 1.30 pm under RNS No 9009Y.

 

The number of ordinary shares sold by Mark Bentley was 77,511, as opposed to 77,476 as previously announced. Accordingly, Mr Bentley's retained interest in ordinary shares is now 337,968, as opposed to 338,003 as previously announced.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

20 May 2016

Cello Group plc

("Cello" or the "Company")

 

Director's dealing

 

The Company has been notified that on 20 May 2016 the following directors of the Company exercised options under the PSP Option Scheme 2010 ("PSP") and the Approved Share Option Plan 2009 ("Approved") in order to increase their stakes in the Company.

Details of the exercise of options by the directors are set out below:

Director

Option Scheme

No of options held prior to exercise

No of options exercised

Exercise Price

No of options held post exercise

Mark Scott

PSP

1,550,000

770,000

10p

780,000

Mark Scott

Approved

72,000

72,000

31.5p

-

Mark Bentley

PSP

605,000

130,000

10p

475,000

Stephen Highley

PSP

420,000

50,000

10p

370,000

 

Following the exercise of these options the directors made the following sale of ordinary shares of 10 pence each in the Company ("Ordinary Shares"), these sales were made to cover exercise, tax and national insurance costs:

Director

No of ordinary shares prior to exercise and sale

No of ordinary shares sold

Sale Price

Retained interest in ordinary shares

% of issued share capital (as enlarged by the issue of options)

Mark Scott

964,379

486,204

97.2p

1,320,175

1.52%

Mark Bentley

285,479

77,511

97.2p

337,968

0.39%

Stephen Highley

2,046,889

22,285

97.2p

2,074,604

2.39%

 

 Contacts:

 

 Cello Group 020 7812 8460

 Mark Scott, Chief Executive

 Mark Bentley, Finance Director

 

 Cenkos Securities 0207 397 8900

 Bobbie Hilliam

 Harry Pardoe

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFFVEDIIFIR
Date   Source Headline
2nd Oct 20198:40 amRNSDisposal
18th Sep 20197:00 amRNSInterim Results
23rd Aug 201910:40 amRNSHolding(s) in Company
16th Aug 20197:00 amRNSAcquisition of ISS
6th Aug 20193:07 pmRNSTotal Voting Rights
6th Aug 20197:00 amRNSNotification of Half Year Results
18th Jul 20197:00 amRNSPre-close Trading Update
20th Jun 20194:29 pmRNSDirector/PDMR Shareholding
10th Jun 20199:41 amRNSTotal Voting Rights
24th May 201912:45 pmRNSBlock listing Interim Review
20th May 20194:29 pmRNSIssue of Equity
15th May 20197:00 amRNSHolding(s) in Company
8th May 20191:30 pmRNSResult of AGM
8th May 20197:00 amRNSAGM Statement
1st May 201912:15 pmRNSTotal Voting Rights
15th Apr 201911:12 amRNSAnnual Report and Notice of AGM
10th Apr 20197:00 amRNSCapital Markets Event
4th Apr 201910:00 amRNSTotal Voting Rights
27th Mar 20191:00 pmRNSHolding(s) in Company
21st Mar 20193:10 pmRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSPreliminary Results
6th Mar 20191:51 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSNotice of Full Year Results
17th Jan 20197:00 amRNSPre-Close Trading Statement
14th Dec 20189:24 amRNSBlock Listing Update
23rd Nov 20183:45 pmRNSHolding(s) in Company
19th Nov 20182:45 pmRNSHolding(s) in Company
12th Nov 201811:30 amRNSDirectorate Change
5th Nov 20182:00 pmRNSDirectorate Change
31st Oct 20183:30 pmRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAppointment of Executive Director
25th Sep 20181:00 pmRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirector/PDMR Shareholding
24th Sep 201811:39 amRNSTransfer of FTSE classification to Healthcare
21st Sep 201810:15 amRNSDirector/PDMR Shareholding
20th Sep 20184:00 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSDirector/PDMR Shareholding
19th Sep 20187:00 amRNSInterim Results
22nd Aug 20181:51 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSNotification of Half Year Results
16th Aug 20182:00 pmRNSTotal Voting Rights
16th Aug 20181:30 pmRNSBoard Changes
23rd Jul 20187:00 amRNSHolding(s) in Company
19th Jul 20187:00 amRNSPre-close Trading Update
17th Jul 20187:00 amRNSChange of registered office
4th Jul 20181:53 pmRNSHolding(s) in Company
27th Jun 201812:46 pmRNSHolding(s) in Company
22nd Jun 20184:47 pmRNSHolding(s) in Company
20th Jun 20182:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.